238 related articles for article (PubMed ID: 24145649)
1. Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
Fadare O; Desouki MM; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Parkash V; Hecht JL
Am J Surg Pathol; 2014 Feb; 38(2):189-96. PubMed ID: 24145649
[TBL] [Abstract][Full Text] [Related]
2. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma.
Lim D; Ip PP; Cheung AN; Kiyokawa T; Oliva E
Am J Surg Pathol; 2015 Aug; 39(8):1061-9. PubMed ID: 25871622
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Fadare O; Zhao C; Khabele D; Parkash V; Quick CM; Gwin K; Desouki MM
Pathology; 2015 Feb; 47(2):105-11. PubMed ID: 25551297
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma.
Li Q; Zeng X; Cheng X; Zhang J; Ji J; Wang J; Xiong K; Qi Q; Huang W
Int J Clin Exp Pathol; 2015; 8(7):8305-10. PubMed ID: 26339401
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features.
Fadare O; Parkash V; Dupont WD; Acs G; Atkins KA; Irving JA; Pirog EC; Quade BJ; Quddus MR; Rabban JT; Vang R; Hecht JL
Am J Surg Pathol; 2012 Aug; 36(8):1107-18. PubMed ID: 22790851
[TBL] [Abstract][Full Text] [Related]
7. Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Miller EM; Tymon-Rosario J; Sunkara J; Harmon BE; Karabakhtsian RG; Novetsky AP
Int J Gynecol Cancer; 2018 Sep; 28(7):1318-1324. PubMed ID: 30036224
[TBL] [Abstract][Full Text] [Related]
8. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
10. Expression of tissue factor and heparanase in endometrial clear cell carcinoma: possible role for tissue factor in thromboembolic events.
Fadare O; Renshaw IL; Liang SX
Int J Gynecol Pathol; 2011 May; 30(3):252-61. PubMed ID: 21464728
[TBL] [Abstract][Full Text] [Related]
11. The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
Kandalaft PL; Gown AM; Isacson C
Am J Clin Pathol; 2014 Dec; 142(6):830-6. PubMed ID: 25389337
[TBL] [Abstract][Full Text] [Related]
12. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
[TBL] [Abstract][Full Text] [Related]
13. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.
Gilks CB; Oliva E; Soslow RA
Am J Surg Pathol; 2013 Jun; 37(6):874-81. PubMed ID: 23629444
[TBL] [Abstract][Full Text] [Related]
14. Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
Fadare O; Parkash V; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Rawish KR; Hecht JL; Desouki MM
Hum Pathol; 2013 Dec; 44(12):2814-21. PubMed ID: 24119561
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of HNF1β, Napsin A and P504S/Alpha-Methylacyl-CoA Racemase (AMACR) as markers of endometrial clear cell carcinoma.
Travaglino A; Raffone A; Arciuolo D; Santoro A; Inzani F; Di Maio A; Visiello U; Fulgione C; Guida M; Mollo A; Insabato L; Zannoni GF
Pathol Res Pract; 2022 Sep; 237():154019. PubMed ID: 35907281
[TBL] [Abstract][Full Text] [Related]
16. Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Al-Maghrabi JA; Butt NS; Anfinan N; Sait K; Sait H; Marzouki A; Khabaz MN
Appl Immunohistochem Mol Morphol; 2017 Oct; 25(9):632-638. PubMed ID: 26945446
[TBL] [Abstract][Full Text] [Related]
17. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Bishop JA; Sharma R; Illei PB
Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
[TBL] [Abstract][Full Text] [Related]
18. Expression of placental leucine aminopeptidase is associated with a poor outcome in endometrial endometrioid adenocarcinoma.
Shibata K; Kikkawa F; Suzuki Y; Mizokami Y; Kajiyama H; Ino K; Nomura S; Nagasaka T; Mizutani S
Oncology; 2004; 66(4):288-95. PubMed ID: 15218296
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W
Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504
[TBL] [Abstract][Full Text] [Related]
20. Precursors of endometrial clear cell carcinoma.
Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
